-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
G1 Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2015 to 2022.
- G1 Therapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $121K, a 6.92% decline year-over-year.
- G1 Therapeutics, Inc. Depreciation for the twelve months ending June 30, 2024 was $881K, a 63.8% increase year-over-year.
- G1 Therapeutics, Inc. annual Depreciation for 2022 was $530K, a 13% increase from 2021.
- G1 Therapeutics, Inc. annual Depreciation for 2021 was $469K, a 19.4% decline from 2020.
- G1 Therapeutics, Inc. annual Depreciation for 2020 was $582K, a 63.5% increase from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)